The neurobiology of apathy in depression and neurocognitive impairment in older adults: a review of epidemiological, clinical, neuropsychological and biological research

Нейробиология апатии при депрессии и нейрокогнитивных нарушениях у пожилых людей: обзор эпидемиологических, клинических, нейропсихологических и биологических исследований
David C. Steffens, Mario Fahed, Kevin J. Manning, Lihong Wang
2022-12-26

ApathyDepressionNeurocognitive impairmentNeuroimagingPrefrontal cortex circuits
Apathy is a common condition that involves diminished initiative, diminished interest and diminished emotional expression or responsiveness. It is highly prevalent in the context of a variety of neuropsychiatric disorders and is related to poor health outcomes. Presence of apathy is associated with cognitive and functional decline in dementia. Despite its negative impact on health, there is no definitive treatment for apathy, a clinical reality that may be due in part to lack of knowledge about assessment, neuropsychological features and neurobiological underpinnings. Here, we review and synthesize evidence from clinical, epidemiological, neuropsychological, peripheral biomarker and neuroimaging research. Apathy is a common feature of depression and cognitive disorders and is associated with impairment in executive function. Neuropsychological and neuroimaging studies point to dysfunction of brain circuitry involving the prefrontal cortex, especially the dorsolateral prefrontal cortex circuit, the dorsomedial prefrontal cortex circuit, and the ventromedial prefrontal cortex circuit. However, inconsistent findings, particularly in neuroimaging may be due to heterogeneity of apathy symptoms (with a need to better elucidate subtypes), neuropsychiatric comorbidities, the severity of cognitive impairment and other factors. These factors need to be accounted for in future studies so that biomarker research can make progress. On the whole, the literature on apathy has identified likely neurocognitive, peripheral biomarker and neuroimaging targets for understanding apathy, but also points to the need to address methodological issues that will better inform future studies. In turn, as we learn more about the underpinning of apathy and its subtypes, subsequent research can focus on new neurally based interventions that will strengthen the clinical management of apathy in the context of its comorbidities.
1
Apathy is associated with executive-function impairment, cognitive and functional decline in dementia, and poor health outcomes.
2
Apathy, characterized by reduced initiative, interest, and emotional responsiveness, is common in depression and cognitive disorders among older adults.
3
Evidence implicates dysfunction in prefrontal circuitry, particularly dorsolateral, dorsomedial, and ventromedial prefrontal cortex circuits.
4
Inconsistent neuroimaging findings may reflect heterogeneity of apathy symptoms, neuropsychiatric comorbidities, cognitive-impairment severity, and other methodological factors.
5
The review identifies promising neurocognitive, peripheral biomarker, and neuroimaging targets, while emphasizing that no definitive treatment exists and improved methodology is needed to guide neurally based interventions.

Apathy in older adults with depression and neurocognitive impairment

The epidemiological, clinical, neuropsychological, peripheral biomarker, and neuroimaging characteristics and neurobiological underpinnings of apathy, including executive-function impairment and prefrontal-circuit dysfunction

Publication Details
Publication Date
2022-12-26
Journal
Publisher
ISSN
Cited by
113
Access Type
Author Information
Authors
David C. Steffens
Mario Fahed
Kevin J. Manning
Lihong Wang
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%